Sökresultat

Filtyp

Din sökning på "*" gav 130573 sökträffar

The government appoints a member of the Geodata Council from the GIS center

Lars Harrie, professor at the Department of Physical Geography and Ecosystem Science (INES) and GIS Center, has been appointed a member of the National Geodata Council, representing universities and colleges. The Council aims to develop strategies and activities to ensure that geographical data can be used in, for example, climate change adaption, the creation of sustainable cities and disaster ma

https://www.nateko.lu.se/article/government-appoints-member-geodata-council-gis-center - 2026-01-11

Copernicus publishes dataset - researchers from our department contribute

Copernicus has published a dataset that shows growing seasons and vegetation productivity in great detail. Researchers from the department - Lars Eklundh, Zhanzhang Cai and Hongxiao Jin - have developed the algorithms that form the basis of the databases. Copernicus Land Monitoring Service (CLMS), a service that provides geographic data from satellites, has recently published a large dataset cover

https://www.nateko.lu.se/article/copernicus-publishes-dataset-researchers-our-department-contribute - 2026-01-11

Our researchers in “The battle of the forest”

Forest management in the climate debate is splitting the forest community of researchers, forest owners, organisations and companies. Which way is the right way to go to make forestry work to help to counteract climate change? Several of our researchers appear in this, and professor emeritus Anders Lindroth explains his view on today´s forest management. Swedish National television program Vetensk

https://www.nateko.lu.se/article/our-researchers-battle-forest - 2026-01-11

Dr. Weiming Huang awarded best PhD thesis

Weiming Huang is awarded in EuroSDR Award winner 2021 for the best PhD thesis related to geoinformation science for his thesis about knowledge-based geospatial data integration and visualisation with Semantic Web technologies. The thesis was presented during the 139th EuroSDR Board of Delegates meeting on October 22, 2021. Dr. Weiming Huang has been awarded by the European Spatial Data Research fo

https://www.nateko.lu.se/article/dr-weiming-huang-awarded-best-phd-thesis - 2026-01-11

ICOS supports science and policy making – first comprehensive article describing ICOS published

The increasing amount of greenhouse gases in the atmosphere are causing our climate to warm at an alarming rate. The consequent changes are unprecedented, and difficult to predict due to the complexity of the Earth system.  While we know that half of the carbon emissions released to the atmosphere by fossil fuel usage are re-captured by the ocean and land ecosystems, we still lack knowledge when i

https://www.nateko.lu.se/article/icos-supports-science-and-policy-making-first-comprehensive-article-describing-icos-published - 2026-01-11

A new reliable blood marker reveals the extent of Alzheimer’s pathology in the brain

Researchers at Lund University and Washington University have identified a blood marker that reflects the amount of Alzheimer’s pathology in the brain. This discovery may play a key role in determining who is most likely to benefit from the new Alzheimer’s drugs. In brief:A newly discovered blood marker, MTBR-tau243, can reveal how much Alzheimer’s disease pathology is present in the brain. The hi

https://www.multipark.lu.se/article/new-reliable-blood-marker-reveals-extent-alzheimers-pathology-brain - 2026-01-11

More opportunities to test for Alzheimer’s using new analytical method

A simpler method of analysing blood samples for Alzheimer’s disease has been tested in a large multicentre study, led by Lund University in Sweden. “This is a major step in bringing simple blood tests for Alzheimer’s disease into the healthcare system globally,” say the researchers behind the study. In brief:The blood-based marker (P-tau217) may start to change several years before the onset of Al

https://www.multipark.lu.se/article/more-opportunities-test-alzheimers-using-new-analytical-method - 2026-01-11

Meet Our Scientists Podcast: Gesine Paul-Visse about the brain’s frontline

Meet our scientist Gesine Paul-Visse to learn what happens at the interface where the brain and the body meet: the blood-brain barrier. Here, a very specialized cell, the pericyte, protects the brain and responds strongly to disease. Gesine Paul-Visse leads Translational Neurology, one of MultiPark’s research groups. As both a neurologist and a researcher, she has focused on neurodegeneration for

https://www.multipark.lu.se/article/meet-our-scientists-podcast-gesine-paul-visse-about-brains-frontline - 2026-01-11

Protein mismanagement in brain's control center fuels early symptoms in neurodegenerative diseases

Researchers at MultiPark have uncovered in mice how the protein TDP-43, known for its role in several neurodegenerative diseases, disrupts the hypothalamus, the brain’s key center for metabolic control. Their study sheds new light on the role of TDP-43 in metabolic and psychiatric symptoms shared across frontotemporal dementia, Huntington’s disease, and ALS – findings that could support the develo

https://www.multipark.lu.se/article/protein-mismanagement-brains-control-center-fuels-early-symptoms-neurodegenerative-diseases - 2026-01-11

Brain activation pattern behind impulsivity in Parkinson’s treatment discovered

An experimental study from Lund University reveals for the first time that different Parkinson’s medications affect brain activity in distinct ways. This could explain why some patients develop impulsive and compulsive behaviors as a result of their treatment. The findings have been published in NPJ Parkinson’s Disease. Upon receiving treatment for their motor symptoms, many patients with Parkinso

https://www.multipark.lu.se/article/brain-activation-pattern-behind-impulsivity-parkinsons-treatment-discovered - 2026-01-11

Meet Our Scientists Podcast: Niklas Mattsson-Carlgren about biomarkers and the future of Alzheimer’s

Meet our scientist, Dr. Niklas Mattsson-Carlgren! He explains why studying biomarkers is essential to advancing Alzheimer’s research. Niklas Mattsson-Carlgren is part of the Clinical Memory Research group, a leading centre in the development and evaluation of novel biomarkers for Alzheimer’s disease. In this podcast episode, he discusses why biomarker research is key not only to detecting but also

https://www.multipark.lu.se/article/meet-our-scientists-podcast-niklas-mattsson-carlgren-about-biomarkers-and-future-alzheimers - 2026-01-11

Alzheimer’s awareness: Five research projects shaping the future of understanding, diagnosis and care

With over 15 research groups dedicated to Alzheimer’s disease research, MultiPark’s goal is to understand the origins of the disease, develop early diagnostics, and improve treatments. The multidisciplinary approach sheds light on the disease from several angles, bridging basic research with clinical investigations. Here are five projects. September is World Alzheimer’s Month. Globally, around 40

https://www.multipark.lu.se/article/alzheimers-awareness-five-research-projects-shaping-future-understanding-diagnosis-and-care - 2026-01-11

Why repetitive DNA matters for human brain evolution and disease

For decades, large stretches of human DNA were dismissed as ‘junk’ and considered to serve no real purpose. In a new study in Cell Genomics, researchers at Lund University in Sweden show that the repetitive part of the human genome plays an active role during early brain development and may also be relevant for understanding brain diseases. DNA carries the complete set of instructions an organism

https://www.multipark.lu.se/article/why-repetitive-dna-matters-human-brain-evolution-and-disease - 2026-01-11

TIME to unite lab and clinic – 1.5 million € to build an AI model of Alzheimer’s disease

Enormous amounts of data about Alzheimer’s Disease have been generated from clinical studies so far. Still, the molecular drivers of Alzheimer’s Disease are largely unknown. With the TAU-TIME project, Jacob Vogel aims to advance knowledge by developing an AI tool that brings together known biological mechanisms with data from patients with the disease. Recent funding from the European Research Cou

https://www.multipark.lu.se/article/time-unite-lab-and-clinic-15-million-eu-build-ai-model-alzheimers-disease - 2026-01-11

Smell test cuts need for invasive Parkinson’s screening

Early diagnosis is key to receiving proper care and advancing research on future therapies for neurodegenerative diseases such as Parkinson’s and dementia with Lewy bodies. New research from Skåne University Hospital and Lund University shows that combining a simple smell test with advanced spinal fluid analysis can predict these diseases with high accuracy, while sparing nearly half of patients f

https://www.multipark.lu.se/article/smell-test-cuts-need-invasive-parkinsons-screening - 2026-01-11

New digital cognitive test for diagnosing Alzheimer's disease

Researchers at Lund University in Sweden have developed a digital cognitive test for diagnosing Alzheimer's disease that is intended for use in primary care. “This digital test, which patients perform on their own with minimal involvement from healthcare personnel, improves the primary care physician's ability to determine who should be further examined by blood tests for Alzheimer's pathology ear

https://www.multipark.lu.se/article/new-digital-cognitive-test-diagnosing-alzheimers-disease - 2026-01-11

Meet Our Scientists Podcast: Cecilia Lundberg about the gene workshop

What if brain diseases could be cured by turning on the proper genes? Meet our scientist, Professor Cecilia Lundberg! She explains how gene therapy may complement cell therapies to combat Parkinson’s disease. Cecilia Lundberg is head of the CNS Gene Therapy Research Group and has spent her whole career developing cutting-edge tools that may be used in future therapies to slow down or cure neurodeg

https://www.multipark.lu.se/article/meet-our-scientists-podcast-cecilia-lundberg-about-gene-workshop - 2026-01-11

Meet Our Scientists Podcast: Per Odin about the Parkinson’s journey

Have you ever wondered what the journey of someone living with Parkinson’s disease looks like? Meet our scientist, Professor Per Odin! He shares his experiences of the bumpy road faced by patients he has supported over the years, both in healthcare and in research studies. Parkinson’s disease is a long, challenging course; one that science works tirelessly to understand, where halting neurodegener

https://www.multipark.lu.se/article/meet-our-scientists-podcast-odin-about-parkinsons-journey - 2026-01-11

Largest ever TauPET study of Alzheimer’s deepens understanding of the disease

In a study led by Lund University and the Amsterdam University Medical Center, researchers used PET to analyse aggregates of tau pathology in more than 12,000 people from all over the world. The study – the largest ever of its kind – examines the connection between genetic predisposition, gender and age in relation to tau pathology in Alzheimer’s disease. The study is published in Nature Neuroscie

https://www.multipark.lu.se/article/largest-ever-taupet-study-alzheimers-deepens-understanding-disease - 2026-01-11

MultiPark scientists awarded prestigious VR consolidator grant

With an approval rate of just 17 %, this year’s Swedish Research Council grants were harder than usual to secure. Still, several of MultiPark’s group leaders were awarded major grants in Medicine and Health 2025. Receiving grants from the Swedish Research Council is seen as a mark of quality and an important step in advancing an independent research group. Recently, six MultiPark researchers were

https://www.multipark.lu.se/article/multipark-scientists-awarded-prestigious-vr-consolidator-grant - 2026-01-11